PF-07321332
Product Sizes
2 mg
£168.00
F1000-2MG
10 mg
£308.00
F1000-10MG
50 mg
£542.00
F1000-50MG
100 mg
£775.00
F1000-100MG
About this Product
- SKU:
- F1000
- Buffer:
- Powder; no buffer
- Extra Details:
- PF-07321332 is an orally active covalent inhibitor of the 3C-like protease by direct binding of the catalytic cysteine 145. 3CL protease cleaves polyproteins 1a and 1ab of SARS-CoV-2, a step required for reproduce the virus. The PF-07321332/ritonavir combination drug (trade name Paxlovid) is efficient for the treatment of COVID-19 as, in November 2021, Pfizer announced phase 2/3 clinal trial results that the drug treatment reduced 89% in hospitalizations when given within three days after symptom onset. This product is for research use only.
- Molecular Weight:
- 499.53 g/mol
- Shipping Conditions:
- Ambient
- Source:
- chemical synthesis
- Storage Conditions:
- -20 0C
- Supplier:
- UBP Bio
- Type:
- Proteins, Peptides, Small Molecules & Other Biomolecules
